Circadian distribution of iron and ferritin in serum of healthy and type 2 diabetic males.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16669550)

Published in Clin Ter on May 03, 2006

Authors

J L H C Third1, M D Ryan, R B Sothern, S Dawson, J B McCormick, H S Hoffman, A Gathing, R A Jankowski, K S Kania, E L Kanabrocki

Author Affiliations

1: Cardiology Laboratory, Edward Hines, Jr Veterans Medical Center, Hines, IL 60141, USA.

Articles by these authors

Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85

A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27

Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20

Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81

Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol (2001) 4.25

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24

The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol (2001) 3.95

Transport of live animals for slaughter. Vet Rec (1991) 3.83

A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51

Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21

Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94

Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65

Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57

Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44

Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ (2000) 2.33

The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect (1997) 2.27

Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14

Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet (1984) 2.12

Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09

Menstrual influence on surgical cure of breast cancer. Lancet (1989) 2.08

Acute sensorineural deafness in Lassa fever. JAMA (1990) 2.02

Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA (1987) 1.98

Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94

Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol (2001) 1.94

Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92

A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax (2007) 1.89

Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89

The cleavage activities of aphthovirus and cardiovirus 2A proteins. J Gen Virol (1997) 1.82

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nat Med (2000) 1.79

Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol (2000) 1.79

Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J Clin Microbiol (1984) 1.78

Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev (1980) 1.76

Effective vaccine for lassa fever. J Virol (2000) 1.74

Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet (1995) 1.72

Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology (1986) 1.69

Seasonal variations in the presentation and growth of thyroid cancer. Br J Cancer (1998) 1.68

Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am J Trop Med Hyg (1993) 1.66

Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66

Organisational change: the key to quality improvement. Qual Health Care (1998) 1.66

Pancreatic enzyme supplement dosage in cystic fibrosis. Lancet (1991) 1.64

Influences on clinical practice: the case of glue ear. Qual Health Care (1999) 1.62

Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson's disease. Eur J Neurol (2009) 1.58

Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men. Am Heart J (2000) 1.58

Wound infection by an indigenous Pseudomonas pseudomallei-like organism isolated from the soil: case report and epidemiologic study. J Infect Dis (1977) 1.57

Radiographic progression of hospital referred osteoarthritis of the hip. Ann Rheum Dis (1993) 1.57

Menstrual history and breast cancer surgery. Breast Cancer Res Treat (1989) 1.55

Methylprednisolone in the management of acute spinal cord injuries. Med J Aust (1990) 1.53

Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med (1975) 1.52

A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ (1988) 1.51

Isolation of B bronchiseptica from kittens with pneumonia in a breeding cattery. Vet Rec (1991) 1.50

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. Am J Trop Med Hyg (1999) 1.49

Hepatitis G virus in Karachi, Pakistan. Lancet (1996) 1.47

Depo-Medrol and myelographic arachnoiditis. Med J Aust (1991) 1.43

Circadian variation in the expression of cell-cycle proteins in human oral epithelium. Am J Pathol (1999) 1.43

The nucleoprotein gene of Ebola virus: cloning, sequencing, and in vitro expression. Virology (1989) 1.42

Behavioral control by an imprinted stimulus. J Exp Anal Behav (1966) 1.41

Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol (1987) 1.40

HFRS after a wild rodent bite in the Haute-Savoie--and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet (1984) 1.38

Extrapulmonary tuberculosis in children. Med J Aust (1993) 1.38

Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg (1988) 1.36

Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol (1991) 1.35

Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Miner Res (1996) 1.35

Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34

Public health considerations in the management of meningococcal disease. Ann Intern Med (1975) 1.32

Power and quality improvement in the new NHS: the roles of doctors and managers. Qual Health Care (1998) 1.32

Radiographic patterns and associations of osteoarthritis of the hip. Ann Rheum Dis (1992) 1.32

Self-processing 2A-polyproteins--a system for co-ordinate expression of multiple proteins in transgenic plants. Plant J (1999) 1.31

Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology (1991) 1.31

Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am J Trop Med Hyg (1986) 1.31

Trends in disease caused by Neisseria meningitidis: 1972 and 1973. J Infect Dis (1974) 1.29

Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiol Infect (1998) 1.29

Hantaan virus: identification of virion proteins. J Gen Virol (1984) 1.27

HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.26

Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet (1985) 1.26

Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala. Arch Virol (1991) 1.26

Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology (1989) 1.25

Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology (1989) 1.25

Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A (1989) 1.25

Collateral behavior of the pigeon during conditioned suppression of key pecking. J Exp Anal Behav (1971) 1.25

Detection of viral antigens in formalin-fixed specimens by enzyme treatment. Ann N Y Acad Sci (1983) 1.23

Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J Gen Virol (1990) 1.23

Risk of human infections with Crimean-Congo hemorrhagic fever virus in a South African rural community. Am J Trop Med Hyg (1992) 1.23

Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med Microbiol Immunol (1986) 1.22

Yersinia enterocolitica infection in a 4-month-old infant associated with infection in household dogs. J Pediatr (1976) 1.21

An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis (1988) 1.21

Construct and face validity of MIST-VR, Endotower, and CELTS: are we ready for skills assessment using simulators? Surg Endosc (2005) 1.21

Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients. Ann Surg (2000) 1.21

Experimental filovirus infections. Curr Top Microbiol Immunol (1999) 1.20

Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J Infect Dis (1982) 1.20

Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J Infect Dis (1987) 1.20

Enabling technologies for manipulating multiple genes on complex pathways. Plant Mol Biol (2001) 1.20

Physicochemical properties of Marburg virus: evidence for three distinct virus strains and their relationship to Ebola virus. J Gen Virol (1988) 1.19

Disease control programs in the United States. Control of streptococcal and poststreptococcal disease. JAMA (1978) 1.19

The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med (1988) 1.19

Epidemic streptococcal sore throat following a community picnic. JAMA (1976) 1.19

Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem (2001) 1.18